ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a targeted pill boost transplant success in older blood cancer patients?
Disease control Recruiting nowThis phase 3 trial compares two conditioning regimens before stem cell transplant in adults over 50 with acute myeloid leukemia or myelodysplastic syndrome. One group gets standard chemotherapy (fludarabine + melphalan), the other adds venetoclax, a targeted pill. The goal is to …
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 17, 2026 00:50 UTC
-
Tailored transplant doses aim to improve blood cancer outcomes
Disease control Recruiting nowThis study tests a personalized approach to stem cell transplants for adults with blood cancers like leukemia and lymphoma. The intensity of chemotherapy and radiation is adjusted based on each patient's risk level to try to improve survival and reduce side effects. About 60 part…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated May 11, 2026 20:39 UTC